What is RadMD?
RadMD operates as an expertise-based image management service organization. The company provides comprehensive consulting, training, and independent imaging services tailored for pharmaceutical, biotechnology, and medical device firms. With a proven track record, RadMD has designed and executed imaging endpoints for over 600 studies, leveraging a large consortium of independent readers. Furthermore, the organization has trained more than 1,000 sites to enhance image assessment protocols, underscoring its deep domain expertise in clinical imaging analysis.
How much funding has RadMD raised?
RadMD has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in RadMD
PPP
Public-Private Partnership
What's next for RadMD?
The substantial capital infusion, particularly the recent strategic investment, positions RadMD for accelerated expansion and potential market leadership. This financing is indicative of a company in its mature growth phase, likely focusing on scaling operations, enhancing its service offerings, and possibly pursuing strategic acquisitions or partnerships. The company's trajectory suggests a continued emphasis on leveraging its established expertise in imaging services to support the evolving needs of the life sciences sector.
See full RadMD company page
